A stronger than expected read on US inflation sent markets into a dive this week, with tech stocks coping most of the pain. But why is that? And what does it mean for investors? It’s all to do with the ‘cost’ of money — that is, interest rates. When the Continue Reading
higher
Promedicus (ASX:PME) shares rocket higher
There’s plenty to love about medical imaging software powerhouse Promedicus (ASX:PME). A founder led, highly profitable disruptor in a large and fast growing market, the business enjoys potent network effects and high switching costs. The balance sheet is rock-solid, costs are well managed and the business should continue to scale Continue Reading